A Meta-Analysis of Oxidative Stress Markers in Depression
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
OBJECT: Studies have suggested that depression was accompanied by oxidative stress dysregulation, including abnormal total antioxidant capacity (TAC), antioxidants, free radicals, oxidative damage and autoimmune response products. This meta-analysis aims to analyse the clinical data quantitatively by comparing the oxidative stress markers between depressed patients and healthy controls. METHODS: A search was conducted to collect the studies that measured the oxidative stress markers in depressed patients. Studies were searched in Embase, Medline, PsychINFO, Science direct, CBMDisc, CNKI and VIP from 1990 to May 2015. Data were subjected to meta-analysis by using a random effects model for examining the effect sizes of the results. Bias assessments, heterogeneity assessments and sensitivity analyses were also conducted. RESULTS: 115 articles met the inclusion criteria. Lower TAC was noted in acute episodes (AEs) of depressed patients (p<0.05). Antioxidants, including serum paraoxonase, uric acid, albumin, high-density lipoprotein cholesterol and zinc levels were lower than controls (p<0.05); the serum uric acid, albumin and vitamin C levels were increased after antidepressant therapy (p<0.05). Oxidative damage products, including red blood cell (RBC) malondialdehyde (MDA), serum MDA and 8-F2-isoprostanes levels were higher than controls (p<0.05). After antidepressant medication, RBC and serum MDA levels were decreased (p<0.05). Moreover, serum peroxide in free radicals levels were higher than controls (p<0.05). There were no differences between the depressed patients and controls for other oxidative stress markers. CONCLUSION: This meta-analysis supports the facts that the serum TAC, paraoxonase and antioxidant levels are lower, and the serum free radical and oxidative damage product levels are higher than controls in depressed patients. Meanwhile, the antioxidant levels are increased and the oxidative damage product levels are decreased after antidepressant medication. The pathophysiological relationships between oxidative stress and depression, and the potential benefits of antioxidant supplementation deserve further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have reported higher levels of oxidative stress byproducts and lower levels of antioxidant enzymes (103).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Pooled effect sizes (ES) were calculated according to DerSimonian and Laird for the random effects model because of the diversity of methods, patients’ clinical statuses and treatments [27].”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“Newcastle-Ottawa Scale (NOS) (case control studies or cohort studies) [26].”
MethodOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Depression affects millions of people and is the leading global cause of disability according to the World Health Organization [1].”
BackgroundOxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · cited 1×
“Oxidative stress is defined as a persistent imbalance between oxidation and anti-oxidation, which leads to the damage of cellular macromolecules [14, 15].”
BackgroundBilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Meta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491
Research works printed but not linked: 32
- N Bal, 2012, Altered Levels of Malondialdehyde and Vitamin E in Major Depressive Disorder and Generalized Anxiety Disorder, Dusunen Adam: Journal of Psychiatry & Neurological Sciences, 25, 206
- ZP Qian, 2012, A study of correlation between serum zinc and lithium levels of depressed patients, Medical Laboratory Science and Clinics, 23, 64
- Y Chen, 2010, A study of serum IL-1β, IL-6 and blood SOD levels in patients of depression, Neural Injury and Functional Reconstruction January, 5, 74
- JM Hu, 1996, Analysis of superoxide dismutase activity of red blood cell in patients with schizophrenia and depression, Chinese Journal of Nervous and Mental Diseases, 22, 86
- ZZ Huang, 1999, Study on lipid peroxide, superoxide dismutase and glutathione peroxidase in patients with affective disorder, Chin J Psychiatry, 32, 191
- J He, 2000, The clinical study of antioxidative capacity in psychiatry patients, Chinese Journal of Behavio ral Medical Science, 9, 139
- XH Zhang, 1997, Changes of plasma SOD activity and MDA level in patients with depression and anxiety, Journal of Convalescen and Rehabilitation, 12, 157
- SL Wen, 2013, Analysis on serum levels of non-enzyme antioxidants and intelligence quotient in patients with recurrent depression, Chin Prev Med, 14, 579
- MF Chen, 2010, Analysis on serum levels of uric acid in patients with depression, Chin J Prev Chron Dis, 18, 302
- MF Chen, 2012, Plasma Non-enzyme Antioxidants Levels in the Depressive Patients with Attempted Suicide, Chin J Prev Chron Dis, 20, 529
- J Lu, 2010, The effect of escitalopram on serum glucose and lipids, Medical Journal of Chinese People’s Health, 22, 2242
- YG Yuan, 2002, Serum lipid concentrations in patients with comorbid anxiety and depression, Chin J Nerv Ment Dis, 28, 33
- YG Yuan, 2006, A study of serum lipid concentrations and apolipoprotein E genotype among patients with senile depression and alzhemier disease, Chinese General Practice, 9, 106
- YG Yuan, 2003, The relation ship between plasma monoamine neurotransmitters and serum lipid concentrations in depressive patients, J Clin Psychol Med, 13, 67
- XB Huang, 2003, Serum lipid and catecholamin concentrations in patients with anxiety and depression, J Clin Psychol Med, 13, 94
- MD Wu, 2004, A study of serum lipid concentrations in 536 patients of psychiatric disorders, Journal of Sichuan Continuing Education College of MS, 23, 175
- XH Wang, 2014, A study of physical function, serum lipids and cytokines in 48 uygur elderly patients with depression, Xinjiang Medical Journal, 44, 61
- YC Lv, 2011, Analysis of suicidal behavior and detection of biological parameter in patients with depressive disorder, Journal of Medical Forum, 32, 7
- GH Wang, 2003, The levels of the cholesterol, triglyceride, lipoprotein, apolipoprotein in young depression patients, MedicaI JournaI of Wuhan University, 24, 174
- RP Che, 2014, The study on lipid metabolism in 86 patients with first episode depression, Journal of Practical Medical Techniques, 21, 664
- WJ Zhang, 2012, The clinical study of serum thyroid hormone and lipid levels in patients with first episode depression, Chin J Lab Diagn, 16, 712
- QC Xia, 2009, Study of metabolism of glucose and lipid in patients of first-episode depressioon, J Clin Psychiatry, 19, 241
- CY Li, 2011, The comparative study on serum glucose and lipids in patients with first episode depression, Medical Journal of ChinesePeople’s Health, 23, 1355
- WL He, 2013, Research on lipid metabolism of the first-episode patients with depression, World Health Digest Medical Periodieal, 10, 413
- YM Jiao, 2006, Fasting blood glucose and serum lipid level in patients with major depression and their relations to psychopathology, Shanghai Archives of Psychiatry, 18, 266
- FX Wu, 1998, Depression and hemorheology, J Clin Psychol Med, 8, 341
- HY Yu, 1997, The mearsure of trace element in red blood cell and serum of depressed patients, Hebei Mental Health, 10, 10
- MD Fernández-González, 1998, Trace elements in serum of psychiatric outpatients, Química Clínica, 17, 208
- XR Chang, 2001, The mearsure of serum 14 kinds of trace element in patients of depression, Chinese Journal of Behavioral Medical Science, 10, 589
- XQ Guo, 2011, A study of serum ten kinds of trace element level changes in depressed patients, China Health Monthly, 1, 136
- GF Wu, 2012, A study of correlation between cytokine, serum zinc level, thyroid hormone and depression, The Public Health, 6, 61
- XW Xu, 2010, The mearsure of MAO, MDA, hs-CRP levels and their clinical meaning in patients of depression, Medical Innovation of Chin, 7, 175
Cited by
Items 201–300 of 484
Zhang, T., & Kong, J. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1567603 · Cited by 19
“Research has illustrated that increased levels of oxidative stress are closely linked to anxiety and depression symptoms in PTSD patients (Liu et al., 2015).”
Houminer-Klepar, N., & Dopelt, K. (2025) · Foods · doi:10.3390/foods14091485 · Cited by 22
“…explain the link between diet and mental health, including systemic inflammation, oxidative stress, and bidirectional communication via the gut–brain axis, where dietary components influence gut microbiota composition and function, affecting neurotransmitter production and neural signaling [15,16].”
Üstündağ, Y., Huysal, K., Kahvecioğlu, S., Demirci, H., Yavuz, Ş., Şambel, M., & Ünal, D. (2016) · The European Research Journal · doi:10.18621/eurj.2016.5000190265 · Cited by 19
“, vitamin E), are present in extracellular fluids [2, 3].”
BackgroundBilginer, Ç., Yaman, H., Karadeniz, S., Bulut, S. H., Yaman, S. Ö., & Aydoğdu, S. (2021) · Psychiatria Danubina · doi:10.24869/psyd.2021.158 · Cited by 21
“Malondialdehyde (MDA), one of the final products of lipid peroxidation, has been extensively investigated as an oxidative damage index in adult patients with major depressive disorder; however, these studies present conflicting data (Jordan et al. 2018, Liu et al. 2015).”
ResultFidilio, A., Grasso, M., Caruso, G., Musso, N., Begni, V., Privitera, A., Torrisi, S. A., Campolongo, P., Schiavone, S., Tascedda, F., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1075746 · Cited by 20
“, 2013), and also that stress-related conditions are followed by changes in the pro-oxidant/antioxidant ratio in various tissues (Liu et al., 2015; Moniczewski et al., 2015).”
BackgroundA review of new insights into existing major depressive disorder biomarkers
Rimti, F. H., Shahbaz, R., Bhatt, K., & Xiang, A. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18909 · Cited by 23
“There is a hypothesis that when antioxidant defenses and oxidative stress are enhanced in MDD patients, these specific components of oxidative stress can influence the depression pathophysiology [92].”
BackgroundHashimoto, K., Ishima, T., Sato, Y., Bruno, D., Nierenberg, J. J., Marmar, C. R., Zetterberg, H., Blennow, K., & Pomara, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-03836-0 · Cited by 25
“A recent meta-analysis showed that serum levels of ascorbic acid in patients with MDD were lower than controls, and that serum levels of ascorbic acid in patients with MDD were increased after antidepressant therapy (46).”
BackgroundCavicchioli, F. L., Maes, M. H. J., Roomruangwong, C., Bonifácio, K. L., Barbosa, D. S., Anderson, G., Vargas, H. O., & Nunes, S. O. V. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.024 · Cited by 23
“It is well established that serum HDL-cholesterol levels and related cholesterol esterification are significantly lower in MDD and/or BD than in normal controls leading to increased atherogenicity (de Melo et al., 2017 ; Liu et al., 2015; Maes et al., 1994a; Nunes et al., 2015; Vargas et al., 2014).”
Redox metabolism modulation as a mechanism in SSRI toxicity and pharmacological effects
Ștefan, M.-G., Kiss, B., Gutleb, A. C., & Loghin, F. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02721-6 · Cited by 22
Gawlik-Kotelnicka, O., & Strzelecki, D. (2021) · Life · doi:10.3390/life11020117 · Cited by 19
“The presence of higher levels of OxS has also been associated with poorer antidepressant treatment response; in addition, antidepressant use has been found to be associated with a decrease in oxidative and inflammatory markers [39,40].”
BackgroundMorga, P., Cieślik, B., Sekułowicz, M., Bujnowska–Fedak, M. M., Drower, I. S., & Szczepańska-Gieracha, J. (2021) · Journal of Sports Science and Medicine · doi:10.52082/jssm.2021.222 · Cited by 22
“People with MetS have been found to characteristically display higher levels of OS than people without MetS, and the level of OS is directly connected with the incidence of depressive symptoms (Grandl and Wolfrum, 2018; Liu et al., 2015; Lindqvist et al., 2017).”
BackgroundWerneck, A. O., Peralta, M., Tesler, R., & Marques, A. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.09.010 · Cited by 21
Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
Buoli, M., Capuzzi, E., Caldiroli, A., Ceresa, A., Esposito, C. M., Posio, C., Auxilia, A. M., Capellazzi, M., Tagliabue, I., Surace, T., et al. (2022) · Behavioral Sciences · doi:10.3390/bs12020034 · Cited by 21
“Indeed, some antioxidant agents, including serum levels of uric acid, albumin and high-density lipoprotein cholesterol (HDL-C) were found to be lower among depressed patients than controls, whilst some oxidative damage products, including malondialdehyde, were higher than in healthy subjects [17].”
BackgroundMethodThe Wicked Relationship between Depression and Metabolic Syndrome.
Marazziti, D., Arone, A., Palermo, S., Annuzzi, E., Cappellato, G., Chiarantini, I., Prete, L. D., & Dell’Osso, L. (2023) · PubMed Central · doi:10.36131/cnfioritieditore20230202 · Cited by 25
“Depressed patients, when compared to healthy subjects, also seem to show a different activity of several enzymes, such as catalase and glutathione reductase, as their activities tend to be elevated in MDD and restored by antidepressant drugs (Liu et al., 2015).”
BackgroundRamírez-Garza, S. L., Santos, E. P. L., Moreno, J. J., Bodega, P., de Cos-Gandoy, A., de Miguel, M., Santos-Beneit, G., Fernández-Alvira, J. M., Fernández‐Jiménez, R., Martínez‐Gómez, J., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1216445 · Cited by 20
“Furthermore, oxidative stress has been linked with depression (5, 6), whereas a healthy dietary pattern is associated with good mental health (1, 7).”
BackgroundMohammadi, A. H., Balandeh, E., & Milajerdi, A. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00354-2 · Cited by 18
“(2015) reported that the MDA level was higher in patients with depression disorder than controls [37, 38].”
BackgroundKaźmierski, J., Miler, P., Pawlak, A., Jerczyńska, H., Woźniak, J., Frankowska, E., Brzezińska, A., Nowakowska, K., Woźniak, K., Krejca, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03007-2 · Cited by 21
Vitinius, F., Escherich, S., Deter, H., Hellmich, M., Jünger, J., Petrowski, K., Ladwig, K., Lambertus, F., Michal, M., Weber, C., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2026-6 · Cited by 18
Kumar, M., & Chail, M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05259-3 · Cited by 20
Naß, J., Kampf, C. J., & Efferth, T. (2021) · Molecules · doi:10.3390/molecules26071827 · Cited by 21
“Oxidative stress leads to DNA damage, protein damage, and lipid peroxidation [22], which ultimately contribute to concomitant diseases, such as cardiovascular diseases [23].”
BackgroundKarbownik, M. S., Mokros, Ł., & Kowalczyk, E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19073861 · Cited by 20
“Major depression has a strong molecular basis, characterized by excessive oxidative stress and lower antioxidant protection [33,34], resulting in the induction of pro-inflammatory reactions [34–36], and in turn, serotonin depletion [37].”
BackgroundThe impact of chronic stress on intracellular redox balance: A systems level analysis
Geddie, H., Cairns, M., Smith, L., van Wyk, M., Beselaar, L., Truter, N., Rautenbach, F., Marnewick, J. L., Joseph, D. E., & Essop, M. F. (2023) · Physiological Reports · doi:10.14814/phy2.15640 · Cited by 19
“An imbalance between pro- and antioxidants is therefore an attractive theory of neurological dysfunction that is supported by strong evidence (Liu et al., 2015; Miller & Sadeh, 2014; Patel, 2016; Smith et al., 2000).”
BackgroundRoomruangwong, C., Barbosa, D. S., de Farias, C. C., Matsumoto, A. K., Baltus, T. H. L., Morelli, N. R., Kanchanatawan, B., Duleu, S., Geffard, M., & Maes, M. H. J. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12625 · Cited by 17
Apocynin as an antidepressant agent: in vivo behavior and oxidative parameters modulation
Pereira, G. C., Piton, E., dos Santos, B. M., da Silva, R. M., de Almeida, A. S., Dalenogare, D. P., Souto, N. S., Fialho, M. F. P., Moresco, R. N., Trevisan, G., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112643 · Cited by 18
Naß, J., Abdelfatah, S., & Efferth, T. (2021) · Food & Function · doi:10.1039/d0fo02208j · Cited by 22
Mendonça, I. P., de Paiva, I. H. R., Duarte-Silva, E. P., de Melo, M. G., da Silva, R. S., do Nascimento, M. I. X., & Peixoto, C. A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01043-6 · Cited by 18
“2022), oxidative stress (Subramaniam and Chesselet 2013; Liu et al. 2015), cell death (Zhang et al.”
BackgroundIron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation
Dufrusine, B., Valentinuzzi, S., Bibbò, S., Damiani, V., Lanuti, P., Pieragostino, D., Boccio, P. D., D’Alessandro, E., Rabottini, A., Berghella, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010015 · Cited by 19
Sepehrmanesh, Z., Omidi, A., & Gholampoor, N. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.33243 · Cited by 19
“There is also evidence to indicate that oxidative stress and reduced antioxidant function play a role in depression (45).”
BackgroundBonifácio, K. L., Barbosa, D. S., Moreira, E. G., de Farias, C. C., Vargas, H. O., Nunes, S. O. V., Moraes, J. B., & Maes, M. H. J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.040 · Cited by 19
Malondialdehyde and bipolar disorder: A short comprehensive review of available literature
Caldiroli, A., Auxilia, A. M., Capuzzi, E., Clerici, M., & Buoli, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.001 · Cited by 20
Réus, G. Z., Abitante, M. S., Manosso, L. M., de Moura, A. B., Borba, L. A., Botelho, M. E. M., Darabas, A. C., Demo, J. P., Behenck, J. P., Arent, C. O., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02588-3 · Cited by 19
Gong, Y., Lu, Z., Kang, Z., Feng, X., Zhang, Y., Sun, Y., Chen, W., Xun, G., & Yue, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1019618 · Cited by 18
“For instance, retinol is essential for embryonic development, especially for the development of the brain, meanwhile, the ascorbate, as a neuroprotective compound, is highly concentrated in the brain and regulates the function of neurons and synapses (12, 18, 19).”
BackgroundTutan, D., Kaya, A. E., & Eser, B. (2023) · Medicine · doi:10.1097/md.0000000000035197 · Cited by 15
“[37,38] One of the suggested mechanisms through which inflammation affects depression involves the activation of the immune system.”
Kamath, S. U., Chaturvedi, A., Yerrapragada, D. B., Kundapura, N., Amin, N., & Devaramane, V. (2019) · Europe PMC (PubMed Central) · Cited by 24
Koprdová, R., Csatlósová, K., Ďurišová, B., Bögi, E., Májeková, M., Dremencov, E., & Mach, M. (2019) · Molecules · doi:10.3390/molecules24234218 · Cited by 15
“Depression, either diagnosed per se or co-diagnosed with other chronic diseases, is often accompanied with oxidation stress [35,36].”
BackgroundGumpp, A. M., Behnke, A., Bach, A. M., Piller, S., Boeck, C., Rojas, R., & Kolassa, I. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.009 · Cited by 19
Zhao, Q., Zhu, Y., Yeh, F., Lin, J., Lee, E. T., Cole, S. A., Calhoun, D., & Zhao, J. (2016) · Aging · doi:10.18632/aging.101104 · Cited by 16
“While the precise mechanisms linking depression to LTL shortening remain to be determined, it is possible that depression could contribute to shortened LTL through one or more biological pathways known to be involved in depression, such as inflammation [31, 32], oxidative stress [33, 34], hyperactivity of the hypothal…”
Xu, J., Zhu, C., Jin, P., Sun, W., & Yu, E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0289248 · Cited by 14
Xu, Q., Wang, J., Li, H., & Chen, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1453044 · Cited by 15
“After antidepressant treatment, albumin levels gradually increase in depression patients (23).”
BackgroundShangguan, T., Xu, J., Weng, X., & Lin, H. T. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1504123 · Cited by 14
“A decrease in albumin may result in the dysregulation of oxidative stress, with increased levels of free radicals and oxidative injury being observable in patients with depression (64).”
α2-containing γ-aminobutyric acid type A receptors promote stress resiliency in male mice
Benham, R. S., Choi, C., Hodgson, N., Hewage, N. B., Kästli, R., Donahue, R. J., Muschamp, J. W., Engin, E., Carlezon, W. A., Hensch, T. K., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01144-w · Cited by 16
Kwok, J., Speyer, L. G., Soursou, G., Murray, A. L., Fanti, K. A., & Auyeung, B. (2023) · BMC Medicine · doi:10.1186/s12916-023-02835-5 · Cited by 14
“In addition, the cord blood marker of lowered HDL, also classified as an oxidative stress marker [43], presents an early insight into how it can affect a child’s personal, social, and emotional domain, with studies supporting associations when examining oxidative stress dysregulation being found in patients with depre…”
BackgroundTsuboi, H., Sakakibara, H., Tatsumi, A., Yamakawa‐Kobayashi, K., Matsunaga, M., Kaneko, H., & Shimoi, K. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.031 · Cited by 14
Maes, M. H. J., Barbosa, D. S., Almulla, A. F., & Kanchanatawan, B. (2022) · Antioxidants · doi:10.3390/antiox11050803 · Cited by 15
Zohrabi, T., Ziaee, A., Salehi‐Abargouei, A., Ferns, G. A., Ghayour‐Mobarhan, M., & Khayyatzadeh, S. S. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03589-4 · Cited by 13
“In this regard, higher adherence to DTAC potentiate antioxidant levels, while lower free radical and oxidative stress in depressed patients [40].”
BackgroundThiol/Disulfide Homeostasis in Bipolar and Unipolar Depression
Erzın, G., Özkaya, G., Topçuoğlu, C., Yüksel, R. N., Erel, Ö., Yurt, E. F., Göka, E., & Gülöksüz, S. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.3.395 · Cited by 13
“The recent meta-analysis shows that following an antidepressant medication, the antioxidant levels increase, while the oxidative damage product levels decrease [42].”
BackgroundCross-National Variations in COVID-19 Mortality: The Role of Diet, Obesity and Depression
Rajkumar, R. P. (2021) · Diseases · doi:10.3390/diseases9020036 · Cited by 15
Savage, K. M., Gogarty, L., Lea, A., Deleuil, S., Nolidin, K., Croft, K. D., & Stough, C. K. K. (2022) · Antioxidants · doi:10.3390/antiox11050822 · Cited by 17
Gallic Acid from Terminalia Bellirica Fruit Exerts Antidepressant-like Activity
Yadavalli, C. S., Kumar, G. P., & Raghavan, A. K. (2020) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-020-00020-w · Cited by 16
“Previous studies have demonstrated that depression was accompanied by oxidative stress (Liu et al. 2015).”
BackgroundPotential biomarkers of emotional stress induced neurodegeneration
Zafar, T. (2020) · eNeurologicalSci · doi:10.1016/j.ensci.2020.100292 · Cited by 14
Urine 3-Nitrotyrosine and serum HDL as potential biomarkers of depression
Nobis, A., Zalewski, D., Samaryn, E., Maciejczyk, M., Zalewska, A., & Waszkiewicz, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12010377 · Cited by 12
“The main ROS include hydrogen peroxide, hydroxy radical, and superoxide anion [4].”
BackgroundZhu, H., Tao, R., Yu, Q., Yu, M., Zhou, Y., & Fu, Q. (2025) · BMC Public Health · doi:10.1186/s12889-025-22880-4 · Cited by 13
“After receiving drug treatment, the level of albumin in patients with depression can increase, further confirming that the decrease in albumin levels may play an important biological bridging role between DEET exposure and depression [69].”
Abramova, O. V., Zorkina, Y., Syunyakov, T., Zubkov, E. A., Ushakova, V. M., Silantyev, A., Soloveva, K., Gurina, O. I., Majouga, A. G., Morozova, A. Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179598 · Cited by 13
“There are different protection systems and mechanisms in the body to cope with overproduction of pro-oxidants, but they can be intruded upon by different pathological states [65,67,71].”
BackgroundAlmohaimeed, H. M., Hamed, S. M., Seleem, H. S., Batawi, A. H., Mohammedsaleh, Z. M., Balgoon, M. J., Ali, S. S., Jaouni, S. K. A., & Ayuob, N. N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749766 · Cited by 14
Loo, J. L., Kamal, N. A. M., Goon, J. A., Damanhuri, H. A., Tan, J. A. C., Murad, N. A. A., Shah, S. A., Sulaiman, S. A., Fazry, S., Sharip, S., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.698911 · Cited by 12
Morris, G., Walder, K. R., Berk, M., Carvalho, A. F., Marx, W., Bortolasci, C. C., Yung, A. R., Puri, B. K., & Maes, M. H. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110481 · Cited by 13
Antidepressant Like Effect of Ascorbic Acid in Mice: Possible Involvement of NO-sGC-cGMP Signaling
Maratha, S. R., Sharma, V., & Walia, V. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03496-7 · Cited by 13
“Depression is also characterized by the elevated level of oxidative stress markers [73].”
BackgroundOriolo, G., Blanco‐Hinojo, L., Navinés, R., Mariñó, Z., Martín‐Hernández, D., Cavero, M., Giménez, M. D., Caso, J. R., Capuron, L., Forns, X., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.008 · Cited by 14
Zhang, Y., Bi, Y., Chen, J., Li, S., Wu, X., Zhang, L., Lin, Z., Han, S., & Ding, S. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.11.010 · Cited by 13
Self-citationYan, T., Liu, B., Li, F., Wu, B., Xiao, F., He, B., & Jia, Y. (2021) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2021.1879847 · Cited by 13
Self-citationCoccini, T., Ottonello, M., Spigno, P., Malovini, A. L., Fiabane, E., Roda, E., Signorini, C., & Pistarini, C. (2021) · Alcohol · doi:10.1016/j.alcohol.2021.04.004 · Cited by 12
Effect of Musa sapientum stem extract on animal models of depression
Dubey, A., Reddy, A. J., Handu, S. S., Mediratta, P. K., Shukla, R., & Ahmed, Q. (2016) · Pharmacognosy Research · doi:10.4103/0974-8490.188876 · Cited by 12
“It was further seen that there was an increase in the antioxidant levels and decrease in the oxidative damage product levels after antidepressant medication.[15] In the light of the evidence of antioxidant activity in M.”
BackgroundCarroll, A. J., Huffman, M. D., Zhao, L., Jacobs, D. R., Stewart, J. C., Kiefe, C. I., Liu, K., & Hitsman, B. L. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000667 · Cited by 12
“One meta-analysis also concluded that antidepressant treatment was associated with lower levels of oxidative stress markers (17).”
Hagen, J. M., Sutterland, A. L., de Sousa, P. A. L. D. F. P., Schirmbeck, F. N., Cohn, D. M., Lok, A., Tan, H. L., Zwinderman, A. H., & de Haan, L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.040 · Cited by 12
Almohaimeed, H. M., Batawi, A. H., Mohammedsaleh, Z. M., Jaouni, S. K. A., Alsawat, S. A. M., Wahab, M. G. A. E., AbdElfattah, A. A., & Ayuob, N. N. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.704180 · Cited by 11
Foshati, S., Ghanizadeh, A. J., & Akhlaghi, M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14254 · Cited by 14
Chebieb, I., Dennouni-Medjati, N., Harek, Y., Guermouche, B., Dali-Sahi, M., Kachekouche, Y., & Benosman, C. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03858-y · Cited by 16
“The nervous system appears to be particularly vulnerable to oxidative damage, due to its high demand for energy and oxygen and the nature of its cell membrane rich in highly peroxidizable polyunsaturated fatty acids [11].”
Zhang, J., Kong, D.-L., Xiao, B., Yuan, H.-J., Kong, Q.-Q., Xiao, H., Luo, M., & Tan, J. (2020) · Zygote · doi:10.1017/s0967199419000844 · Cited by 11
“MDA is well known as a marker for oxidative stress (Liu et al., 2015), and its level has been measured in spermatozoa to reflect a state of oxidative stress (Moazamian et al., 2015).”
BackgroundKoga, M., Toda, H., Kinoshita, M., Asai, F., Nagamine, M., Shimizu, K., Kobayashi, Y., Morimoto, Y., & Yoshino, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109978 · Cited by 12
Durmaz, O., İspir, E., Baykan, H., Alışık, M., & Erel, Ö. (2017) · Journal of Ect · doi:10.1097/yct.0000000000000467 · Cited by 14
Bisle, E., Haange, S., Rojas, R., Behnke, A., Karabatsiakis, A., Gumpp, A. M., Mack, M., Mavioğlu, R. N., Lutz‐Bonengel, S., Rolle-Kampczyk, U. E., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116569 · Cited by 10
Júnior, A. L. G., Tchekalarova, J. D., Machado, K. D. C., Silva, S. W. C., Paz, M. F. C. J., Nogueira, T. R., Lira, B. S. D. M. M., Zihad, S. M. N. K., Islam, M. T., Ali, E. S., et al. (2019) · Phytotherapy Research · doi:10.1002/ptr.6407 · Cited by 10
“Additionally, depression is well reported to be associations with oxidative stress (Liu et al., 2015).”
Backgrounddos Santos, B. M., Pereira, G. C., Piton, E., Fialho, M. F. P., Becker, G., Carlotto, M. D. S., Camargo, L. F. M., Ramanzini, L. G., Oliveira, S. M., Trevisan, G., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113815 · Cited by 13
Skowrońska, A., Gawlik-Kotelnicka, O., Margulska, A., & Strzelecki, D. (2023) · Metabolites · doi:10.3390/metabo13020182 · Cited by 11
Shishido, R., Kunii, Y., Hino, M., Izumi, R., Nagaoka, A., Hayashi, H., Kakita, A., Tomita, H., & Yabe, H. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1183696 · Cited by 10
“php?page=trimmomatic 33), α-synuclein (SNCA), β-synuclein (SNCB), and γ-synuclein (SNCG) (34, 35), and (iii) molecules whose expression reported to be altered by stress, however, the direction of change in expression by stress varies from literature and is inconsistent, namely apolipoprotein A1 (ApoA1) and ApoA2 (36,…”
BackgroundResultInfluentialThe Changes of Blood and CSF Ion Levels in Depressed Patients: a Systematic Review and Meta-analysis
Meng, Y., Liu, S., Yu, M., Liang, H., Yu, T., Song, J. S., Shi, J., Wen, C., Wu, Q., Wen, Z., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03891-x · Cited by 14
Camkurt, M. A., Fındıklı, E., Tolun, F. İ., Bakacak, M., Bal, N. G., Sakallı, H., & Güneş, M. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.03.054 · Cited by 10
“According to recent meta-analyses, oxidative stress takes an important place in the neurobiology of major depression (Black et al., 2015; Liu et al., 2015; Palta et al., 2014).”
Ghavidel, N., Khodagholi, F., Ahmadiani, A., Khosrowabadi, R., Asadi, S., & Shams, J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s237528 · Cited by 10
“Consistent with our findings, a meta-analysis reported that in depressed patients the antioxidant and serum PON1 levels decreased while the serum-free radical levels increased.(32) Other studies have shown that comorbidity of tobacco use disorder or smoking with mood disorders are associated with the lower anti-oxidan…”
ResultPańczyszyn-Trzewik, P., Stachowicz, K., Misztak, P., Nowak, G., & Sowa-Kućma, M. (2024) · Pharmaceuticals · doi:10.3390/ph17060762 · Cited by 11
“Several studies reported lower TAC levels in acute depressive episodes of depressed patients [56].”
BackgroundCampisi, S. C., Zasowski, C., Shah, S., Bradley-Ridout, G., Madigan, S. L., Szatmári, P., & Korczak, D. J. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab088 · Cited by 12
Bisle, E., Varadarajan, S., & Kolassa, I. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100790 · Cited by 13
Farhan, M., & Faisal, M. (2024) · Life · doi:10.3390/life14101342 · Cited by 12
“A change in the redox state has been observed in the central nervous system of patients with depression, and oxidative abnormalities have been linked to decreased levels of certain endogenous antioxidative enzymes [12].”
BackgroundRotter, I., Wiatrak, A., Rył, A., Kotfis, K., Ciosek, Ż., Laszczyńska, M., Sipak‐Szmigiel, O., & Szylińska, A. (2020) · Medicina · doi:10.3390/medicina56030125 · Cited by 10
“This element also helps to reduce oxidative stress that leads to neurodegeneration and cell death in the nervous system [42,44].”
BackgroundKurkinen, K., Kärkkäinen, O. K., Lehto, S. M., Luoma, I., Kraav, S., Nieminen, A. I., Kivimäki, P., Therman, S., & Tolmunen, T. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100261 · Cited by 10
Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders
Bliźniewska-Kowalska, K. M., Gałecki, P., Su, K., Halaris, A. E., Szemraj, J., & Gałecka, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123321 · Cited by 11
“The levels of antioxidants increased and the levels of oxidative damage products decreased after anti-depressant pharmacotherapy [28].”
BackgroundMethodCamilleri, C., Beiter, R. M., Puentes, L., Aracena-Sherck, P., & Sammut, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00544 · Cited by 9
“As previously mentioned, this corresponded to a lower GSH/GSSG ratio and a higher redox potential, indicative of a lower antioxidant capacity (Schafer and Buettner, 2001; Wu et al., 2004; Maes et al., 2011; Zitka et al., 2012; Liu et al., 2015).”
BackgroundInfluentialSohn, H., Kwon, M., Lee, S., Oh, J., Kim, M., Lee, S., Lee, K. S., & Kim, B. (2018) · Psychiatry Investigation · doi:10.30773/pi.2017.12.17.e1 · Cited by 9
Influence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies
Kwon, S., & Cheon, S. Y. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.2005027 · Cited by 9
Gawlik-Kotelnicka, O., Margulska, A., Gabryelska, A., Sochal, M., Białasiewicz, P., & Strzelecki, D. (2022) · Metabolites · doi:10.3390/metabo12020152 · Cited by 8
la Rosa, L. R.-D., Cervantes‐Pérez, E., Robledo-Valdez, M. A., Cervantes‐Guevara, G., Cervantes‐Cardona, G. A., Ramírez-Ochoa, S., González‐Ojeda, A., Fuentes‐Orozco, C., Cervantes-Pérez, G., Cervantes-Pérez, L. A., et al. (2022) · Revista de Nutrición Clínica y Metabolismo · doi:10.35454/rncm.v5n1.358 · Cited by 17
Soltani, S., Beigrezaei, S., Abdollahi, S., Clark, C. C. T., & Ashoori, M. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-04889-2 · Cited by 9
“Poor vitamin D status is associated with many health problems in children and adolescents, including increased risk of rickets [8], asthma [9], attention deficit hyperactivity disorder (ADHD) [10], autism spectrum disorder [11, 12], infections [9, 13], and type 1 diabetes [14].”
BackgroundZhao, S. S., Qian, Y., Mackie, S. L., Wen, C., & Mao, Y. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05718-3 · Cited by 10
“Previous observational studies have consistently showed lower serum urate levels in people with anxiety and/or depression [6, 16].”
Yang, M., Qin, X., & Liu, X. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106087 · Cited by 8
Salahudeen, T., Maalouf, M., Elfadel, I. M., & Jelinek, H. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320955 · Cited by 8
Oxidative Stress in Treatment-Resistant and Refractory Depression: A Hidden Therapeutic Target?
Winczewska, Z., Cubała, W. J., Radziwiłłowicz, P., & Górska‐Ponikowska, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05715-0 · Cited by 9
de Aquino, G. Â., de Sousa, C. N. S., Medeiros, I. D. S., de Almeida, J. C., Filho, F. M. S. C., Júnior, M. A. S., & Vasconcelos, S. M. M. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0056 · Cited by 9
Antidepressant medication use and prostate cancer recurrence in men with depressive disorders
Haque, R., Reading, S. R., Irwin, M. R., Chen, L. H., & Slezak, J. M. (2022) · Cancer Causes & Control · doi:10.1007/s10552-022-01623-5 · Cited by 10
Oxidative Stress is a New Avenue for Treatment of Neuropsychiatric Disorders: Hype of Hope?
Negah, S. S., & Forouzanfar, F. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230904150907 · Cited by 8
Matison, A. P., Thalamuthu, A., Flood, V. M., Catts, V. S., Christensen, K., Nygaard, M., Pedersen, N. L., Sachdev, P. S., Reppermund, S., & Mather, K. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-79963-2 · Cited by 10
Physical Activity and Depression in Breast Cancer Patients: Mechanisms and Therapeutic Potential
Li, A., Zheng, X., Liu, D., Huang, R., Ge, H., Cheng, L. J., Zhang, M., & Cheng, H. (2025) · Current Oncology · doi:10.3390/curroncol32020077 · Cited by 8
Metadata
- Authors
- Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y.
- Affiliations
- Jinan University (CN)
- Corresponding author
- Jia, Yanbin
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-07
- Volume
- 10
- Issue
- 10
- Pages
- e0138904
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4596519
- OpenAlex
- W2105160377
- Cited by
- 485
- References
- 125
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 42 · 2023: 54 · 2022: 51 · 2021: 78 · 2020: 63 · 2019: 39 · 2018: 43 · 2017: 27 · 2016: 15
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jinan University
- Department of Education of Guangdong Province
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, oxidative stress, total antioxidant capacity, antioxidants, paraoxonase, uric acid, malondialdehyde, 8-isoprostane, free radicals, oxidative damage, antidepressant treatment, acute depressive episode, antioxidant supplementation
- MeSH terms
- Albumins, Antidepressive Agents, Antioxidants, Ascorbic Acid, Cross-Sectional Studies, Depression, Depressive Disorder, Humans, Lipoproteins, HDL, Malondialdehyde, Uric Acid, Lipid Peroxidation, Biomarkers, Case-Control Studies, Oxidative Stress, F2-Isoprostanes, Aryldialkylphosphatase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.